Literature DB >> 10690545

Alterations in the expression of the DNA repair/redox enzyme APE/ref-1 in epithelial ovarian cancers.

D H Moore1, H Michael, R Tritt, S H Parsons, M R Kelley.   

Abstract

The DNA base excision repair pathway is responsible for the repair of alkylation and oxidative DNA damage. A crucial step in the base excision repair pathway involves the cleavage of an apurinic/apyrimidinic (AP) site in DNA by an AP endonuclease (APE). The major AP endonuclease in mammalian cells is APE/ref-1, a multifunctional enzyme that acts not only as an AP endonuclease but as a redox-modifying factor for a variety of transcription factors. The purpose of this study was to determine the expression of APE/redox factor-1 (ref-1) in ovarian tissues, particularly ovarian cancers. Formalin-fixed, paraffin-embedded specimens of ovarian tissues (normal, various benign conditions, and epithelial cancers) were studied using both polyclonal and monoclonal antibodies to APE/ref-1. The relationship between APE/ref-1 protein levels and DNA repair activity was studied in ovarian Hey and Hey-C2 cell lines using Western blot and a specific AP-site oligonucleotide cleavage assay. Hey and Hey-C2 cells were fractionated, and the nuclear and cytoplasmic extracts were quantitated for protein levels and assessed for APE/ref-1 with Western blot. Normal ovarian tissues consistently demonstrated strong nuclear staining of the surface epithelium, epithelial inclusions, corpora lutea and albicantia, and stroma. Cytoplasmic staining was absent. A similar pattern was seen for benign conditions including endometriosis. Low malignant potential ovarian cancers stained in a pattern similar to normal ovarian and nonneoplastic tissues; however, two specimens also had areas of cytoplasmic staining. Epithelial ovarian cancers were remarkably different from all other ovarian tissues studied. Both nuclear and cytoplasmic staining of the malignant epithelium were seen and ranged from strong to weak, often with considerable staining heterogeneity within the same tumor. The AP-site oligonucleotide cleavage assay indicated that APE/ref-1 protein levels correlate well with DNA repair activity. The increased levels of APE/ref-1 in the Hey-C2 cells was mainly attributable to increased cytoplasmic enzyme. APE/ref-1 immunoreactivity is altered in malignant ovarian tumors. Further studies will determine whether the altered expression and subcellular location reflect changes in redox regulatory functions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10690545

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  34 in total

Review 1.  APE1/Ref-1 role in redox signaling: translational applications of targeting the redox function of the DNA repair/redox protein APE1/Ref-1.

Authors:  Mark R Kelley; Millie M Georgiadis; Melissa L Fishel
Journal:  Curr Mol Pharmacol       Date:  2012-01       Impact factor: 3.339

2.  miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway.

Authors:  Yuki Takagawa; Yasuyuki Gen; Tomoki Muramatsu; Kousuke Tanimoto; Jun Inoue; Hiroyuki Harada; Johji Inazawa
Journal:  Mol Ther       Date:  2020-04-11       Impact factor: 11.454

3.  Reduced expression of DNA repair and redox signaling protein APE1/Ref-1 impairs human pancreatic cancer cell survival, proliferation, and cell cycle progression.

Authors:  Yanlin Jiang; Shaoyu Zhou; George E Sandusky; Mark R Kelley; Melissa L Fishel
Journal:  Cancer Invest       Date:  2010-11       Impact factor: 2.176

4.  Age- and tissue-specific changes in mitochondrial and nuclear DNA base excision repair activity in mice: Susceptibility of skeletal muscles to oxidative injury.

Authors:  Bartosz Szczesny; Anne W Tann; Sankar Mitra
Journal:  Mech Ageing Dev       Date:  2010-04-02       Impact factor: 5.432

5.  [Fluorescence assay for the detection of apurinic/apyrimidinic endonuclease 1 (APE1) activity in human blood samples].

Authors:  J Y Wang; M P Zhao
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-06-18

6.  Design and activity of AP endonuclease-1 inhibitors.

Authors:  Zhiwei Feng; Stanton Kochanek; David Close; LiRong Wang; Ajay Srinivasan; Abdulrahman A Almehizia; Prema Iyer; Xiang-Qun Xie; Paul A Johnston; Barry Gold
Journal:  J Chem Biol       Date:  2015-04-19

7.  Ape1/Ref-1 induces glial cell-derived neurotropic factor (GDNF) responsiveness by upregulating GDNF receptor alpha1 expression.

Authors:  Mi-Hwa Kim; Hong-Beum Kim; Samudra Acharya; Hong-Moon Sohn; Jae Yeoul Jun; In-Youb Chang; Ho Jin You
Journal:  Mol Cell Biol       Date:  2009-02-02       Impact factor: 4.272

Review 8.  Redox regulation of DNA repair: implications for human health and cancer therapeutic development.

Authors:  Meihua Luo; Hongzhen He; Mark R Kelley; Millie M Georgiadis
Journal:  Antioxid Redox Signal       Date:  2010-06-01       Impact factor: 8.401

9.  Colon cancer progression is driven by APEX1-mediated upregulation of Jagged.

Authors:  Mi-Hwa Kim; Hong-Beum Kim; Sang Pil Yoon; Sung-Chul Lim; Man Jin Cha; Young Jin Jeon; Sang Gon Park; In-Youb Chang; Ho Jin You
Journal:  J Clin Invest       Date:  2013-07-01       Impact factor: 14.808

10.  Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides.

Authors:  J P Lau; K L Weatherdon; V Skalski; D W Hedley
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.